Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction
https://jamanetwork.com/journals/jama/fullarticle/2853274
This prospective randomized open, blinded end-point adjudication study examines evolocumab as first-line therapy vs standard care in patients with high-risk acute myocardial infarction undergoing percutaneous coronary intervention.
1August 29, 2026 426 2